Back to Search
Start Over
BETTING ON BORON.
- Source :
-
Chemical & Engineering News . 3/21/2011, Vol. 89 Issue 12, p18-19. 2p. 1 Color Photograph. - Publication Year :
- 2011
-
Abstract
- The article discusses the case of Anacor Pharmaceuticals which is developing a family of boron-containing small-molecule drugs. It cites that the company is being assisted by contract research company Naeja Pharmaceuticals and has licensed one of the molecules to GlaxoSmithKline. It details the identification of the target of the compound AN2690 called LeuRS. It mentions that Anacor launched Phase III clinical trials for AN2690 in December 2010.
- Subjects :
- *BORON
*DRUG development
*TARGETED drug delivery
*CLINICAL trials
*THERAPEUTICS
Subjects
Details
- Language :
- English
- ISSN :
- 00092347
- Volume :
- 89
- Issue :
- 12
- Database :
- Academic Search Index
- Journal :
- Chemical & Engineering News
- Publication Type :
- Periodical
- Accession number :
- 59707058
- Full Text :
- https://doi.org/10.1021/cen-v089n026.p018